Trimebutine maleate and pinaverium bromide for irritable bowel syndrome a review of the clinical effectiveness, safety and guidelines
The purpose of this report is to review the clinical effectiveness and safety of trimebutine maleate and pinaverium bromide for the treatment of adult and adolescent patients with irritable bowel syndrome (IBS) and to review the evidence-based guidelines on the use of these two agents for IBS.
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH Rapid Response Service
2015, 30 November 2015
|
Series: | Rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this report is to review the clinical effectiveness and safety of trimebutine maleate and pinaverium bromide for the treatment of adult and adolescent patients with irritable bowel syndrome (IBS) and to review the evidence-based guidelines on the use of these two agents for IBS. |
---|---|
Physical Description: | 1 PDF file (25 pages) illustration |